SCR-LIP-000708 · Claim · machine-readable JSON →

Imaging and body-composition measures are proposed as diagnostic adjuncts, but their diagnostic performance and reliability remain insufficiently established.

General proposition consolidated from 8 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
8 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20192026Lipedema and Dercum's Disease: A New Application of Bioimpedance — Crescenzi et al. (2019) · refiningLipedema—Pathogenesis, Diagnosis, and Treatment Options — Kruppa et al. (2020) · consistentBody Composition Assessment by Dual-Energy X-Ray Absorptiometry: A Useful Tool for the Diagnosis of Lipedema — Buso et al. (2022) · refiningLipedema: What we don’t know — van la Parra et al. (2023) · consistentEditorial for “Subcutaneous Adipose Tissue Edema in Lipedema Revealed by Noninvasive 3T Magnetic Resonance Lymphangiography” — Wang (2023) · consistentDiagnostic imaging in lipedema: A systematic review — van la Parra et al. (2024) · consistentAssessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review — Eason et al. (2025) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · consistent

Evidence (8)

Context (PECO)

Populationwomen with suspected or confirmed lipedema
Conditionlipedema
Exposuremultimodal imaging (ultrasound, lymphoscintigraphy, CT, MRI, MR lymphangiography, DXA)
Outcomediagnostic performance for lipedema characterization
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log